Start for free
Start for free
Palo Alto Investors logo

Palo Alto Investors

North America, California, United States, Palo Alto

Description

Palo Alto Investors is an investment advisor providing money management services.

Investor Profile

Palo Alto Investors has made 30 investments, with 0 in the past 12 months and 7% as lead.

Stage Focus

  • Series D (23%)
  • Series A (17%)
  • Series B (17%)
  • Post Ipo Equity (13%)
  • Series C (13%)
  • Series Unknown (10%)
  • Private Equity (3%)
  • Debt Financing (3%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Transportation
  • Automotive
  • Autonomous Vehicles
  • Electric Vehicle
  • Wireless
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Palo Alto Investors frequently co-invest with?

Kleiner Perkins
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 3
Shepherd Ventures
Shepherd Ventures
North America, California, United States, San Diego
Co-Investments: 3
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 5
Alloy Ventures
Alloy Ventures
North America, California, United States, Palo Alto
Co-Investments: 3
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners
North America, California, United States, Palo Alto
Co-Investments: 3
CHL Medical Partners
CHL Medical Partners
North America, Connecticut, United States, Stamford
Co-Investments: 3
Nexit Ventures
Nexit Ventures
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 3
Delphi Ventures
Delphi Ventures
North America, California, United States, San Mateo
Co-Investments: 3
Vivo Capital
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 5
Mobius Venture Capital
Mobius Venture Capital
North America, Colorado, United States, Boulder
Co-Investments: 3

Which angels does Palo Alto Investors often collaborate with?

BM
Burton McMurtry
North America, California, United States, Milpitas
Shared Deals: 1
VV
Val Vaden
North America, California, United States, Burlingame
Shared Deals: 1
BN
Barry Newman
North America, California, United States, Los Altos
Shared Deals: 1
AK
Arda Kara
North America, California, United States, San Francisco
Shared Deals: 1
HH
Hoyoung Huh
North America, United States
Shared Deals: 1

What are some of recent deals done by Palo Alto Investors?

VYNE Therapeutics

Menlo Park, California, United States

VYNE Therapeutics is a clinical late-stage biopharmaceutical company developing treatments associated with dermatologic conditions.

Health CarePharmaceuticalTherapeutics
Post Ipo EquityOct 30, 2023
Amount Raised: $88,000,000
Gossamer Bio

San Diego, California, United States

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityJul 20, 2023
Amount Raised: $212,000,000
Peak Bio

Palo Alto, California, United States

Peak Bio is a Biopharmaceutical company that focuses on the drug development to treat Oncology and Inflammatory diseases.

BiopharmaBiotechnologyOncology
Post Ipo EquityNov 2, 2022
Amount Raised: $25,000,000
Gilgamesh Pharmaceuticals

New York, New York, United States

Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.

BiotechnologyHealth CareMedicalPharmaceutical
Series AMay 6, 2021
Amount Raised: $27,000,000
NewLeaf Symbiotics

St Louis, Missouri, United States

NewLeaf Symbiotics is an agtech company focused on developing sustainable agricultural products using bacteria and related microbes.

AgricultureBiotechnologySustainability
Series BSep 15, 2014
Amount Raised: $17,000,000
NeXeption

Malvern, Pennsylvania, United States

NeXeption is a biopharmaceutical company bringing together expertise, management and funding for partnerships.

BiopharmaBiotechnologyHealth Care
Series AJan 2, 2014
Amount Raised: $21,500,000
Alimera Sciences

Alpharetta, Georgia, United States

Alimera Sciences is a biopharmaceutical company that focuses on retinal health.

BiotechnologyHealth CareMedical
Post Ipo EquityJul 18, 2012
Amount Raised: $40,000,000
Ceptaris Therapeutics

Malvern, Pennsylvania, United States

Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.

BiotechnologyHealth CareMedicalTherapeutics
Series DJun 5, 2012
Amount Raised: $10,000,000
Ceptaris Therapeutics

Malvern, Pennsylvania, United States

Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.

BiotechnologyHealth CareMedicalTherapeutics
Series DAug 11, 2011
Amount Raised: $14,400,000
Revance Therapeutics

Newark, California, United States

Revance is a biotechnology company focusing on aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series DJun 10, 2011
Amount Raised: $45,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator